Understanding how respiratory viruses affect vulnerable populations
Systems Immunology profiling of respiratory viral infections in vulnerable populations
This study is looking at how the immune system responds to respiratory viruses in older adults and people with health issues, to find ways to improve prevention and treatment, and it may involve patients sharing samples or information to help with this research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Benaroya Research Inst at Virginia Mason NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11295556 on NIH RePORTER |
What this research studies
This research investigates the immune responses to respiratory viral infections in populations that are particularly at risk, such as the elderly or those with underlying health conditions. By profiling the immune system's reaction to these infections, the study aims to identify specific biomarkers and mechanisms that could lead to better prevention and treatment strategies. Patients may be involved in providing samples or data that help researchers understand how these viruses impact their health.
Who could benefit from this research
Good fit: Ideal candidates include individuals from vulnerable populations, such as the elderly or those with chronic health conditions.
Not a fit: Patients who are healthy and do not have any underlying health issues may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive measures for respiratory viral infections in vulnerable groups.
How similar studies have performed: While the specific approach may be novel, there has been previous research indicating that understanding immune responses can lead to significant advancements in treating viral infections.
Where this research is happening
Seattle, United States
- Benaroya Research Inst at Virginia Mason — Seattle, United States (Active)
Researchers
- Principal investigator: Mikacenic, Carmen R — Benaroya Research Inst at Virginia Mason
- Study coordinator: Mikacenic, Carmen R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.